Friedman H
J Bacteriol. 1966 Oct;92(4):820-7. doi: 10.1128/jb.92.4.820-827.1966.
Friedman, Herman (Albert Einstein Medical Center, Philadelphia, Pa.). Immunological tolerance to microbial antigens. II. Suppressed antibody plaque formation to Shigella antigen by spleen cells from tolerant mice. J. Bacteriol. 92:820-827. 1966.-An indirect, localized, antibody plaque procedure has been used to demonstrate a marked difference in the number of antibody plaques formed with spleen cell suspensions from normal and Shigella-tolerant mice. Whereas challenge with soluble Shigella antigen (SSA) into normal mice, ranging in age from 4 to 40 weeks, resulted in a rapid rise in antibody plaque formation to Shigella-treated sheep erythrocytes, there was only a slight increase in plaque formation with spleen cell suspensions from similarly challenged mice which had been made tolerant to Shigella antigen during neonatal life. Apparently, the suppression of plaque formation to Shigella in tolerant animals was specific, since both Shigella-tolerant and normal mice responded equally well to untreated sheep red blood cells after challenge with sheep erythrocytes only. Spleen cells from nonchallenged Shigella-tolerant mice did not form significant numbers of antibody plaques to SSA-treated red blood cells during an observation period of 4 to 30 weeks after neonatal administration of antigen. "Nonspecific" increases in plaque formation to untreated sheep red cells occurred with spleen cell suspensions from both normal and SSA-tolerant mice after challenge injection with Shigella antigen, with or without sheep erythrocytes. Such a response suggested an adjuvant effect for the endotoxin-containing Shigella antigen even in mice tolerant to the agglutinogenic moiety of SSA. The results of these experiments support the view that specific antibody-forming cells are either absent or in low number in lymphoid tissue from mice specifically tolerant to Shigella antigens. It seems unlikely that the low postchallenge agglutinin titers of tolerant mice are due to suppressed antibody formation by normal numbers of individual antibody-producing cells, or due to "masking" of normal antibody production by persisting circulating antigen.
弗里德曼,赫尔曼(宾夕法尼亚州费城阿尔伯特·爱因斯坦医学中心)。对微生物抗原的免疫耐受性。II. 耐受小鼠脾脏细胞对志贺氏菌抗原的抗体斑形成受抑制。《细菌学杂志》92:820 - 827。1966年。——采用一种间接、局部的抗体斑程序来证明,用正常小鼠和耐受志贺氏菌小鼠的脾脏细胞悬液形成的抗体斑数量存在显著差异。向4至40周龄的正常小鼠注射可溶性志贺氏菌抗原(SSA)后,针对经志贺氏菌处理的绵羊红细胞的抗体斑形成迅速增加,而用同样经刺激但在新生期已对志贺氏菌抗原产生耐受的小鼠的脾脏细胞悬液,斑形成仅有轻微增加。显然,耐受动物中针对志贺氏菌的斑形成抑制是特异性的,因为仅在用绵羊红细胞刺激后,耐受志贺氏菌的小鼠和正常小鼠对未处理的绵羊红细胞反应同样良好。在新生期给予抗原后的4至30周观察期内,未受刺激的耐受志贺氏菌小鼠的脾脏细胞对经SSA处理的红细胞未形成大量抗体斑。在用或未用绵羊红细胞注射志贺氏菌抗原刺激后,正常小鼠和耐受SSA小鼠的脾脏细胞悬液对未处理的绵羊红细胞的斑形成出现“非特异性”增加。这种反应表明,即使在对SSA的凝集原部分产生耐受的小鼠中,含内毒素的志贺氏菌抗原也具有佐剂作用。这些实验结果支持这样一种观点,即特异性耐受志贺氏菌抗原的小鼠的淋巴组织中,特异性抗体形成细胞要么不存在,要么数量很少。耐受小鼠在刺激后凝集素滴度低似乎不太可能是由于正常数量的单个抗体产生细胞的抗体形成受抑制,也不太可能是由于持续循环的抗原“掩盖”了正常抗体产生。